1,340
Views
0
CrossRef citations to date
0
Altmetric
Review

The Advances of Blood Clots Used as Biomaterials in Regenerative Medicine

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 957-969 | Received 06 Mar 2022, Accepted 15 Sep 2022, Published online: 09 Oct 2022

Figures & data

Figure 1. Process of natural clot formation.

The process of natural clot formation with associated factors, tissues and molecules.

Figure 1. Process of natural clot formation.The process of natural clot formation with associated factors, tissues and molecules.

Table 1. Comparative effects of blood clots versus blood clots conjugated with mesenchymal stem cells.

Figure 2. Strategy to use autologous blood clots in regenerative medicine.

The strategy to use autologous blood clots in regenerative medicine, including: 1. blood preparation after being drawn from patients; 2. blood clot forms in vitro and can be conjugated with others, such as drugs, antibiotics, and stem cells; 3. use the conjugated blood clots to repair these injured tissues, such as skin wounds, soft tissues, bone defects, muscle, and tendon tears.

Figure 2. Strategy to use autologous blood clots in regenerative medicine.The strategy to use autologous blood clots in regenerative medicine, including: 1. blood preparation after being drawn from patients; 2. blood clot forms in vitro and can be conjugated with others, such as drugs, antibiotics, and stem cells; 3. use the conjugated blood clots to repair these injured tissues, such as skin wounds, soft tissues, bone defects, muscle, and tendon tears.